IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Humulin is human insulin used for ...

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units/mL, a pre-filled device containing Humulin ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company announced today the launch of the BD™ U-500 Insulin Syringe, the first insulin syringe developed for people ...

BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).

DANBURY, CT-- Biodel Inc. (BIOD) announced positive preliminary results from Study 3-152, a Phase 2a clinical trial comparing Biodel's proprietary, concentrated insulin formulation BIOD-531 to ...

The US Food and Drug Administration (FDA) has approved the first prefilled pen device containing concentrated U-500 strength insulin (Humulin R U-500 KwikPen [insulin human injection] 500 units/mL, ...

Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentrated formulation of insulin. Eli Lilly announced the launch of ...

Insulet To Develop New Version Of The OmniPod Insulin Pump For Use With Humulin R U-500 Concentrated Insulin For People With Type 2 Diabetes Bedford, MA (Marketwired) - Insulet Corporation (NASDAQ: ...

The BD U-500 Insulin Syringe is specifically designed to administer the Humulin R U-500 insulin among patients properly. The Humulin R U-500 insulin is prescribed to patients who need a higher dose of ...